Health2 days ago
Johnson & Johnson Achieves Milestone in Multiple Myeloma Treatment
Johnson & Johnson (NYSE: JNJ) has announced a significant advancement in cancer treatment with the successful results of its late-stage trial for Tecvayli (teclistamab). The study...